Ridgewood Investments’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Ridgewood Investments's PFE Position: Q2 2026 in Review
Ridgewood Investments reduced its Pfizer (PFE) stake by 12% in Q2 2026, selling an estimated $125K and leaving 34,171 shares worth $823K. The position accounts for 0.31% of the portfolio, ranked #104.
Ridgewood Investments first reported a position in PFE in Q2 2018 and has held it in 27 quarters since. The position peaked at $1.59M in Q2 2024. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Ridgewood Investments held 34,171 shares of Pfizer worth $823K as of Q2 2026.
- Ridgewood Investments sold 4,777 Pfizer shares in Q2 2026, an estimated $125K.
- Pfizer made up 0.31% of Ridgewood Investments's portfolio in Q2 2026, its #104 holding.
- Ridgewood Investments first reported a position in Pfizer in Q2 2018 and has held it in 27 quarters since.
- Ridgewood Investments's Pfizer position peaked at $1.59M in Q2 2024.
- 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Ridgewood Investments's 13F filing for Q2 2026, filed 3 Aug 2026.